TipRanks
Niagen Bioscience (DE:OCD1)
FRANKFURT:OCD1
Germany Market
OCD1
Niagen Bioscience
RESEARCH TOOLSreports

Niagen Bioscience (OCD1) Stock News & Sentiment

2 Followers
NAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up
Premium
Company Announcements
NAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up
2M ago
NAGE
Bananas, Bread, Bones…Walmart Seals Healthy Aging Deal With Niagen Bioscience
Premium
Market News
Bananas, Bread, Bones…Walmart Seals Healthy Aging Deal With Niagen Bioscience
2M ago
WMT
NAGE
Niagen Bioscience Under Pressure: FDA-Approved NMN Intensifies Competition, Pricing Strain, and Growth Uncertainty
Premium
Company Announcements
Niagen Bioscience Under Pressure: FDA-Approved NMN Intensifies Competition, Pricing Strain, and Growth Uncertainty
2M ago
NAGE
Analyst Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target Despite 2Q26 Shortfall
Premium
Ratings
Analyst Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target Despite 2Q26 Shortfall
2M ago
NAGE
Niagen Bioscience Reports Strong Q2 Results, Highlights Growth
Premium
Company Announcements
Niagen Bioscience Reports Strong Q2 Results, Highlights Growth
2M ago
8K
NAGE
NAGE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
NAGE Upcoming Earnings Report: What to Expect?
2M ago
NAGE
Niagen Bioscience: Buy Rating Reiterated as Pipeline Advances; 12-Month Price Target Unchanged at $11
Premium
Ratings
Niagen Bioscience: Buy Rating Reiterated as Pipeline Advances; 12-Month Price Target Unchanged at $11
3M ago
NAGE
More DE:OCD1 News >

OCD1 News on the Web

Canaccord Genuity Sticks to Its Buy Rating for Niagen Bioscience (NAGE)
TipRanks News
Bullish
Q2 2026 Niagen Bioscience Inc Earnings Call Transcript
GuruFocus News
Neutral
NAGE Upcoming Earnings Report: What to Expect?
TipRanks News
Neutral
Niagen Bioscience price target lowered to $11 from $12 at Ladenburg
TipRanks News
Bullish
Niagen Bioscience appoints Kale as Senior Director of Global External Research
TipRanks News
Bullish
Niagen Bioscience receives exclusive U.S. RPD, EMA OMPD for NB4168
TipRanks News
Bullish
Niagen Bioscience: Buy Rating Reiterated as Pipeline Advances; 12-Month Price Target Unchanged at $11
TipRanks News
Bullish
Niagen Bioscience launches pharmaceutical program for aging and genetic diseases
TipRanks News
Bullish

News Score - Last 7 Days

Positive
DE:OCD1
Sector Average
Media Buzz
This Week3 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average84%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:OCD1’s Media Buzz Sentiment?
3 articles about DE:OCD1 were published this week. In an average week, 1 articles are published.
    What is DE:OCD1’s weekly average amount of articles?
    In an average week, 1 articles about DE:OCD1 are published.
      What is DE:OCD1’s News Sentiment?
      100% of articles about DE:OCD1 were positive this week, compared to its sector average of 84%.
        Consumer Defensive Stocks that are Trending in the News
        TGTTarget
        BTIBritish American Tobacco
        HRLHormel Foods
        KOCoca-Cola
        RIDYFRidley Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week